This finding is confirmed by the observation that IDH-mutated glioma cells are more sensitive to the inhibition of glutaminase,24 suggesting that glutaminolysis serves as a key compensatory pathway to maintain metabolic homoeostasis. The gene discussed is IDH2; the disease is central nervous system cancer.